Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities

Experimental Eye Research

Volumn 141, Issue , 2015, Pages 42-56

  Fernandes, Kimberly A ^a   Harder, Jeffrey M ^b   Williams, Pete A ^b   Rausch, Rebecca L ^a   Kiernan, Amy E ^a   Nair, K Saidas ^c   Anderson, Michael G ^d,e   John, Simon W M ^b,f   Howell, Gareth R ^b   Libby, Richard T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b JACKSON LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Axonal degeneration; DBA 2J; Genomics; IOP; Mouse genetics; Neurodegeneration; Neuroinflammation; Trabecular meshwork

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMATE TRANSPORTER; MEMBRANE PROTEIN; MYOCILIN; OPTINEURIN; UNCLASSIFIED DRUG; WD REPEAT CONTAINING PROTEIN 36;

ANTERIOR EYE SEGMENT; ARTICLE; CELL DEATH; CONGENITAL GLAUCOMA; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MOUSE; MOUSE MODEL; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPTIC NERVE; PATHOPHYSIOLOGY; PHENOTYPE; PRIMARY CONGENITAL GLAUCOMA; PRIMARY GLAUCOMA; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL; RISK FACTOR; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MICE; RETINAL GANGLION CELLS;

EID: 84945495096     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.06.019     Document Type: Article

References (233)

1. Aihara M., Lindsey J.D., Weinreb R.N. Aqueous humor dynamics in mice. Invest. Ophthalmol. Vis. Sci. 2003, 44:5168-5173.
2. Allingham R.R., Liu Y., Rhee D.J. The genetics of primary open-angle glaucoma: a review. Exp. Eye Res. 2009, 88:837-844.
3. Almasieh M., Wilson A.M., Morquette B., Cueva Vargas J.L., Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 2012, 31:152-181.
4. Anderson D.R., Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest. Ophthalmol. 1974, 13:771-783.
5. Anderson D.R., Hendrickson A.E. Failure of increased intracranial pressure to affect rapid axonal transport at the optic nerve head. Invest. Ophthalmol. Vis. Sci. 1977, 16:423-426.
6. Anderson M.G., Libby R.T., Mao M., Cosma I.M., Wilson L.A., Smith R.S., John S.W. Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol. 2006, 4:20.
7. Anderson M.G., Nair K.S., Amonoo L.A., Mehalow A., Trantow C.M., Masli S., John S.W. GpnmbR150X allele must be present in bone marrow derived cells to mediate DBA/2J glaucoma. BMC Genet. 2008, 9:30.
8. Anderson M.G., Smith R.S., Hawes N.L., Zabaleta A., Chang B., Wiggs J.L., John S.W. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat. Genet. 2002, 30:81-85.
9. Aspelund A., Tammela T., Antila S., Nurmi H., Leppanen V.M., Zarkada G., Stanczuk L., Francois M., Makinen T., Saharinen P., Immonen I., Alitalo K. The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel. J. Clin. Invest. 2014, 124:3975-3986.
10. Avila M.Y., Carre D.A., Stone R.A., Civan M.M. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. Invest. Ophthalmol. Vis. Sci. 2001, 42:1841-1846.
11. Awadalla M.S., Fingert J.H., Roos B.E., Chen S., Holmes R., Graham S.L., Chehade M., Galanopolous A., Ridge B., Souzeau E., Zhou T., Siggs O.M., Hewitt A.W., Mackey D.A., Burdon K.P., Craig J.E. Copy number variations of TBK1 in Australian patients with primary open-angle glaucoma. Am. J. Ophthalmol. 2015, 159:124-130. e121.
12. Baltmr A., Duggan J., Nizari S., Salt T.E., Cordeiro M.F. Neuroprotection in glaucoma - is there a future role?. Exp. Eye Res. 2010, 91:554-566.
13. Bond L.M., Peden A.A., Kendrick-Jones J., Sellers J.R., Buss F. Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane. Mol. Biol. Cell. 2011, 22:54-65.
14. Bosco A., Inman D.M., Steele M.R., Wu G., Soto I., Marsh-Armstrong N., Hubbard W.C., Calkins D.J., Horner P.J., Vetter M.L. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2008, 49:1437-1446.
15. Bosco A., Romero C.O., Breen K.T., Chagovetz A.A., Steele M.R., Ambati B.K., Vetter M.L. Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma. Dis. Model. Mech. 2015, 8:443-455.
16. Boussommier-Calleja A., Bertrand J., Woodward D.F., Ethier C.R., Stamer W.D., Overby D.R. Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. Invest. Ophthalmol. Vis. Sci. 2012, 53:5838-5845.
17. Boussommier-Calleja A., Overby D.R. The influence of genetic background on conventional outflow facility in mice. Invest. Ophthalmol. Vis. Sci. 2013, 54:8251-8258.
18. Brennan F.H., Anderson A.J., Taylor S.M., Woodruff T.M., Ruitenberg M.J. Complement activation in the injured central nervous system: another dual-edged sword?. J. Neuroinflammation 2012, 9:137.
19. Buckingham B.P., Inman D.M., Lambert W., Oglesby E., Calkins D.J., Steele M.R., Vetter M.L., Marsh-Armstrong N., Horner P.J. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 2008, 28:2735-2744.
20. Burdon K.P., Crawford A., Casson R.J., Hewitt A.W., Landers J., Danoy P., Mackey D.A., Mitchell P., Healey P.R., Craig J.E. Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma. Ophthalmology 2012, 119:1539-1545.
21. Burdon K.P., Macgregor S., Hewitt A.W., Sharma S., Chidlow G., Mills R.A., Danoy P., Casson R., Viswanathan A.C., Liu J.Z., Landers J., Henders A.K., Wood J., Souzeau E., Crawford A., Leo P., Wang J.J., Rochtchina E., Nyholt D.R., Martin N.G., Montgomery G.W., Mitchell P., Brown M.A., Mackey D.A., Craig J.E. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat. Genet. 2011, 43:574-578.
22. Casson R.J., Chidlow G., Ebneter A., Wood J.P., Crowston J., Goldberg I. Translational neuroprotection research in glaucoma: a review of definitions and principles. Clin. Exp. Ophthalmol. 2012, 40:350-357.
23. Chang B., Smith R.S., Hawes N.L., Anderson M.G., Zabaleta A., Savinova O., Roderick T.H., Heckenlively J.R., Davisson M.T., John S.W. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat. Genet. 1999, 21:405-409.
24. Chang B., Smith R.S., Peters M., Savinova O.V., Hawes N.L., Zabaleta A., Nusinowitz S., Martin J.E., Davisson M.L., Cepko C.L., Hogan B.L., John S.W. Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2001, 2:18.
25. Chatterjee A., Villarreal G., Oh D.J., Kang M.H., Rhee D.J. AMP-activated protein kinase regulates intraocular pressure, extracellular matrix, and cytoskeleton in trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 2014, 55:3127-3139.
26. Chauhan B.C. Endothelin and its potential role in glaucoma. Can. J. Ophthalmol. 2008, 43:356-360.
27. Chesler E.J., Miller D.R., Branstetter L.R., Galloway L.D., Jackson B.L., Philip V.M., Voy B.H., Culiat C.T., Threadgill D.W., Williams R.W., Churchill G.A., Johnson D.K., Manly K.F. The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics. Mamm. Genome 2008, 19:382-389.
28. Cheung W., Guo L., Cordeiro M.F. Neuroprotection in glaucoma: drug-based approaches. Optom. Vis. Sci. 2008, 85:406-416.
29. Chi Z.L., Akahori M., Obazawa M., Minami M., Noda T., Nakaya N., Tomarev S., Kawase K., Yamamoto T., Noda S., Sasaoka M., Shimazaki A., Takada Y., Iwata T. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum. Mol. Genet. 2010, 19:2606-2615.
30. Chi Z.L., Yasumoto F., Sergeev Y., Minami M., Obazawa M., Kimura I., Takada Y., Iwata T. Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice. Hum. Mol. Genet. 2010, 19:3806-3815.
31. Chong R.S., Martin K.R. Glial cell interactions and glaucoma. Curr. Opin. Ophthalmol. 2015, 26:73-77.
32. Churchill G.A., Airey D.C., Allayee H., Angel J.M., Attie A.D., Beatty J., Beavis W.D., Belknap J.K., Bennett B., Berrettini W., Bleich A., Bogue M., Broman K.W., Buck K.J., Buckler E., Burmeister M., Chesler E.J., Cheverud J.M., Clapcote S., Cook M.N., Cox R.D., Crabbe J.C., Crusio W.E., Darvasi A., Deschepper C.F., Doerge R.W., Farber C.R., Forejt J., Gaile D., Garlow S.J., Geiger H., Gershenfeld H., Gordon T., Gu J., Gu W., de Haan G., Hayes N.L., Heller C., Himmelbauer H., Hitzemann R., Hunter K., Hsu H.C., Iraqi F.A., Ivandic B., Jacob H.J., Jansen R.C., Jepsen K.J., Johnson D.K., Johnson T.E., Kempermann G., Kendziorski C., Kotb M., Kooy R.F., Llamas B., Lammert F., Lassalle J.M., Lowenstein P.R., Lu L., Lusis A., Manly K.F., Marcucio R., Matthews D., Medrano J.F., Miller D.R., Mittleman G., Mock B.A., Mogil J.S., Montagutelli X., Morahan G., Morris D.G., Mott R., Nadeau J.H., Nagase H., Nowakowski R.S., O'Hara B.F., Osadchuk A.V., Page G.P., Paigen B., Paigen K., Palmer A.A., Pan H.J., Peltonen-Palotie L., Peirce J., Pomp D., Pravenec M., Prows D.R., Qi Z., Reeves R.H., Roder J., Rosen G.D., Schadt E.E., Schalkwyk L.C., Seltzer Z., Shimomura K., Shou S., Sillanpaa M.J., Siracusa L.D., Snoeck H.W., Spearow J.L., Svenson K., Tarantino L.M., Threadgill D., Toth L.A., Valdar W., de Villena F.P., Warden C., Whatley S., Williams R.W., Wiltshire T., Yi N., Zhang D., Zhang M., Zou F., Complex Trait C. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 2004, 36:1133-1137.
33. Churchill G.A., Gatti D.M., Munger S.C., Svenson K.L. The diversity outbred mouse population. Mamm. Genome 2012, 23:713-718.
34. Cohan B.E., Bohr D.F. Measurement of intraocular pressure in awake mice. Invest. Ophthalmol. Vis. Sci. 2001, 42:2560-2562.
35. Cone F.E., Gelman S.E., Son J.L., Pease M.E., Quigley H.A. Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection. Exp. Eye Res. 2010, 91:415-424.
36. Crish S.D., Sappington R.M., Inman D.M., Horner P.J., Calkins D.J. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5196-5201.
37. Cross S.H., Macalinao D.G., McKie L., Rose L., Kearney A.L., Rainger J., Thaung C., Keighren M., Jadeja S., West K., Kneeland S.C., Smith R.S., Howell G.R., Young F., Robertson M., van T'Hof R., John S.W., Jackson I.J. A dominant-negative mutation of mouse Lmx1b causes glaucoma and is semi-lethal via LBD1-mediated dimerisation. PLoS Genet. 2014, 10:e1004359.
38. Crowston J.G., Kong Y.X., Trounce I.A., Dang T.M., Fahy E.T., Bui B.V., Morrison J.C., Chrysostomou V. An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse. Exp. Eye Res. 2015, (in this issue).
39. Cvekl A., Tamm E.R. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. Bioessays 2004, 26:374-386.
40. Danesh-Meyer H.V. Neuroprotection in glaucoma: recent and future directions. Curr. Opin. Ophthalmol. 2011, 22:78-86.
41. Ding Q.J., Zhu W., Cook A.C., Anfinson K.R., Tucker B.A., Kuehn M.H. Induction of trabecular meshwork cells from induced pluripotent stem cells. Invest. Ophthalmol. Vis. Sci. 2014, 55:7065-7072.
42. Ermann J., Glimcher L.H. After GWAS: mice to the rescue?. Curr. Opin. Immunol. 2012, 24:564-570.
43. Fan W., Li X., Wang W., Mo J.S., Kaplan H., Cooper N.G. Early involvement of immune/inflammatory response genes in retinal degeneration in DBA/2J mice. Ophthalmol. Eye Dis. 2010, 1:23-41.
44. Fang C., Bernardes-Silva M., Coleman M.P., Perry V.H. The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS. Neuroscience 2005, 135:1107-1118.
45. Fautsch M.P., Howell K.G., Vrabel A.M., Charlesworth M.C., Muddiman D.C., Johnson D.H. Primary trabecular meshwork cells incubated in human aqueous humor differ from cells incubated in serum supplements. Invest. Ophthalmol. Vis. Sci. 2005, 46:2848-2856.
46. Filippopoulos T., Danias J., Chen B., Podos S.M., Mittag T.W. Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest. Ophthalmol. Vis. Sci. 2006, 47:1968-1974.
47. Flammer J., Konieczka K., Flammer A.J. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013, 4:14.
48. Fleischman D., Allingham R.R. The role of cerebrospinal fluid pressure in glaucoma and other ophthalmic diseases: a review. Saudi J. Ophthalmol. 2013, 27:97-106.
49. Gal A., Rau I., El Matri L., Kreienkamp H.J., Fehr S., Baklouti K., Chouchane I., Li Y., Rehbein M., Fuchs J., Fledelius H.C., Vilhelmsen K., Schorderet D.F., Munier F.L., Ostergaard E., Thompson D.A., Rosenberg T. Autosomal-recessive posterior microphthalmos is caused by mutations in PRSS56, a gene encoding a trypsin-like serine protease. Am. J. Hum. Genet. 2011, 88:382-390.
50. Gallenberger M., Kroeber M., Marz L., Koch M., Fuchshofer R., Braunger B.M., Iwata T., Tamm E.R. Heterozygote Wdr36-deficient mice do not develop glaucoma. Exp. Eye Res. 2014, 128:83-91.
51. Gallenberger M., Meinel D.M., Kroeber M., Wegner M., Milkereit P., Bosl M.R., Tamm E.R. Lack of WDR36 leads to preimplantation embryonic lethality in mice and delays the formation of small subunit ribosomal RNA in human cells in vitro. Hum. Mol. Genet. 2011, 20:422-435.
52. Gerber A.L., Harris A., Siesky B., Lee E., Schaab T.J., Huck A., Amireskandari A. Vascular dysfunction in diabetes and glaucoma: a complex relationship reviewed. J. Glaucoma 2014, (in press).
53. Gould D.B., John S.W. Anterior segment dysgenesis and the developmental glaucomas are complex traits. Hum. Mol. Genet. 2002, 11:1185-1193.
54. Gould D.B., Marchant J.K., Savinova O.V., Smith R.S., John S.W. Col4a1 mutation causes endoplasmic reticulum stress and genetically modifiable ocular dysgenesis. Hum. Mol. Genet. 2007, 16:798-807.
55. Gould D.B., Miceli-Libby L., Savinova O.V., Torrado M., Tomarev S.I., Smith R.S., John S.W. Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol. Cell. Biol. 2004, 24:9019-9025.
56. Gould D.B., Reedy M., Wilson L.A., Smith R.S., Johnson R.L., John S.W. Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma. Mol. Cell. Biol. 2006, 26:8427-8436.
57. Gould D.B., Smith R.S., John S.W. Anterior segment development relevant to glaucoma. Int. J. Dev. Biol. 2004, 48:1015-1029.
58. Gregory M.S., Hackett C.G., Abernathy E.F., Lee K.S., Saff R.R., Hohlbaum A.M., Moody K.S., Hobson M.W., Jones A., Kolovou P., Karray S., Giani A., John S.W., Chen D.F., Marshak-Rothstein A., Ksander B.R. Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. PLoS One 2011, 6:e17659.
59. Guo L., Moss S.E., Alexander R.A., Ali R.R., Fitzke F.W., Cordeiro M.F. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest. Ophthalmol. Vis. Sci. 2005, 46:175-182.
60. Haddadin R.I., Oh D.J., Kang M.H., Filippopoulos T., Gupta M., Hart L., Sage E.H., Rhee D.J. SPARC-null mice exhibit lower intraocular pressures. Invest. Ophthalmol. Vis. Sci. 2009, 50:3771-3777.
61. Haddadin R.I., Oh D.J., Kang M.H., Villarreal G., Kang J.H., Jin R., Gong H., Rhee D.J. Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. Invest. Ophthalmol. Vis. Sci. 2012, 53:6708-6717.
62. Harada T., Harada C., Nakamura K., Quah H.M., Okumura A., Namekata K., Saeki T., Aihara M., Yoshida H., Mitani A., Tanaka K. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J. Clin. Invest. 2007, 117:1763-1770.
63. Harder J.M., Fernandes K.A., Libby R.T. The Bcl-2 family member BIM has multiple glaucoma-relevant functions in DBA/2J mice. Sci. Rep. 2012, 2:530.
64. Harvey A.R., Hellstrom M., Rodger J. Gene therapy and transplantation in the retinofugal pathway. Prog. Brain Res. 2009, 175:151-161.
65. Harvey H., Durant S. The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms. Exp. Brain Res. 2014, 232:3363-3377.
66. Hauser M.A., Allingham R.R., Linkroum K., Wang J., LaRocque-Abramson K., Figueiredo D., Santiago-Turla C., del Bono E.A., Haines J.L., Pericak-Vance M.A., Wiggs J.L. Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2006, 47:2542-2546.
67. He Z., Vingrys A.J., Armitage J.A., Nguyen C.T., Bui B.V. Chronic hypertension increases susceptibility to acute IOP challenge in rats. Invest. Ophthalmol. Vis. Sci. 2014, 55:7888-7895.
68. Heavner W., Pevny L. Eye development and retinogenesis. Cold Spring Harb. Perspect. Biol. 2012, 4.
69. Helgason E., Phung Q.T., Dueber E.C. Recent insights into the complexity of tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1. FEBS Lett. 2013, 587:1230-1237.
70. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., Barter J.W., Barbay J.M., Marchant J.K., Mahesh N., Porciatti V., Whitmore A.V., Masland R.H., John S.W. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell. Biol. 2007, 179:1523-1537.
71. Howell G.R., Macalinao D.G., Sousa G.L., Walden M., Soto I., Kneeland S.C., Barbay J.M., King B.L., Marchant J.K., Hibbs M., Stevens B., Barres B.A., Clark A.F., Libby R.T., John S.W. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Invest. 2011, 121:1429-1444.
72. Howell G.R., MacNicoll K.H., Braine C.E., Soto I., Macalinao D.G., Sousa G.L., John S.W. Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma. Neurobiol. Dis. 2014, 71:44-52.
73. Howell G.R., Soto I., Ryan M., Graham L.C., Smith R.S., John S.W. Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. J. Neuroinflammation 2013, 10:76.
74. Howell G.R., Soto I., Zhu X., Ryan M., Macalinao D.G., Sousa G.L., Caddle L.B., MacNicoll K.H., Barbay J.M., Porciatti V., Anderson M.G., Smith R.S., Clark A.F., Libby R.T., John S.W. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J. Clin. Invest. 2012, 122:1246-1261.
75. Hu Y., Park K.K., Yang L., Wei X., Yang Q., Cho K.S., Thielen P., Lee A.H., Cartoni R., Glimcher L.H., Chen D.F., He Z. Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells. Neuron 2012, 73:445-452.
76. Huang W., Xing W., Ryskamp D.A., Punzo C., Krizaj D. Localization and phenotype-specific expression of ryanodine calcium release channels in C57BL6 and DBA/2J mouse strains. Exp. Eye Res. 2011, 93:700-709.
77. Hysi P.G., Cheng C.Y., Springelkamp H., Macgregor S., Bailey J.N., Wojciechowski R., Vitart V., Nag A., Hewitt A.W., Hohn R., Venturini C., Mirshahi A., Ramdas W.D., Thorleifsson G., Vithana E., Khor C.C., Stefansson A.B., Liao J., Haines J.L., Amin N., Wang Y.X., Wild P.S., Ozel A.B., Li J.Z., Fleck B.W., Zeller T., Staffieri S.E., Teo Y.Y., Cuellar-Partida G., Luo X., Allingham R.R., Richards J.E., Senft A., Karssen L.C., Zheng Y., Bellenguez C., Xu L., Iglesias A.I., Wilson J.F., Kang J.H., van Leeuwen E.M., Jonsson V., Thorsteinsdottir U., Despriet D.D., Ennis S., Moroi S.E., Martin N.G., Jansonius N.M., Yazar S., Tai E.S., Amouyel P., Kirwan J., van Koolwijk L.M., Hauser M.A., Jonasson F., Leo P., Loomis S.J., Fogarty R., Rivadeneira F., Kearns L., Lackner K.J., de Jong P.T., Simpson C.L., Pennell C.E., Oostra B.A., Uitterlinden A.G., Saw S.M., Lotery A.J., Bailey-Wilson J.E., Hofman A., Vingerling J.R., Maubaret C., Pfeiffer N., Wolfs R.C., Lemij H.G., Young T.L., Pasquale L.R., Delcourt C., Spector T.D., Klaver C.C., Small K.S., Burdon K.P., Stefansson K., Wong T.Y., Group B.G., Consortium, N., Wellcome Trust Case Control, C., Viswanathan A., Mackey D.A., Craig J.E., Wiggs J.L., van Duijn C.M., Hammond C.J., Aung T. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat. Genet. 2014, 46:1126-1130.
78. Inman D.M., Horner P.J. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 2007, 55:942-953.
79. Ito Y.A., Walter M.A. Genomics and anterior segment dysgenesis: a review. Clin. Exp. Ophthalmol. 2014, 42:13-24.
80. Jacobson N., Andrews M., Shepard A.R., Nishimura D., Searby C., Fingert J.H., Hageman G., Mullins R., Davidson B.L., Kwon Y.H., Alward W.L., Stone E.M., Clark A.F., Sheffield V.C. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum. Mol. Genet. 2001, 10:117-125.
81. Jakobs T.C., Libby R.T., Ben Y., John S.W., Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell. Biol. 2005, 171:313-325.
82. Jiang D., Yang Z., Li S., Xiao X., Jia X., Wang P., Guo X., Liu X., Zhang Q. Evaluation of PRSS56 in Chinese subjects with high hyperopia or primary angle-closure glaucoma. Mol. Vis. 2013, 19:2217-2226.
83. Jo W.K., Law A.C., Chung S.K. The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders. Mol. Psychiatry 2014, 19:159-167.
84. John S.W., Hagaman J.R., MacTaggart T.E., Peng L., Smithes O. Intraocular pressure in inbred mouse strains. Invest. Ophthalmol. Vis. Sci. 1997, 38:249-253.
85. John S.W., Smith R.S., Savinova O.V., Hawes N.L., Chang B., Turnbull D., Davisson M., Roderick T.H., Heckenlively J.R. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 1998, 39:951-962.
86. Joung J.K., Sander J.D. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell. Biol. 2013, 14:49-55.
87. Ju W.K., Kim K.Y., Angert M., Duong-Polk K.X., Lindsey J.D., Ellisman M.H., Weinreb R.N. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest. Ophthalmol. Vis. Sci. 2009, 50:707-716.
88. Ju W.K., Kim K.Y., Duong-Polk K.X., Lindsey J.D., Ellisman M.H., Weinreb R.N. Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma. Mol. Vis. 2010, 16:1331-1342.
89. Ju W.K., Kim K.Y., Lindsey J.D., Angert M., Duong-Polk K.X., Scott R.T., Kim J.J., Kukhmazov I., Ellisman M.H., Perkins G.A., Weinreb R.N. Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve. Invest. Ophthalmol. Vis. Sci. 2008, 49:4903-4911.
90. Justice M.J., Siracusa L.D., Stewart A.F. Technical approaches for mouse models of human disease. Dis. Model. Mech. 2011, 4:305-310.
91. Kim B.S., Savinova O.V., Reedy M.V., Martin J., Lun Y., Gan L., Smith R.S., Tomarev S.I., John S.W., Johnson R.L. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol. Cell. Biol. 2001, 21:7707-7713.
92. Kimura A., Guo X., Noro T., Harada C., Tanaka K., Namekata K., Harada T. Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma. Neurosci. Lett. 2015, 588:108-113.
93. Kizhatil K., Ryan M., Marchant J.K., Henrich S., John S.W. Schlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLoS Biol. 2014, 12:e1001912.
94. Krishnamoorthy R.R., Rao V.R., Dauphin R., Prasanna G., Johnson C., Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can. J. Physiol. Pharmacol. 2008, 86:380-393.
95. Kroeber M., Davis N., Holzmann S., Kritzenberger M., Shelah-Goraly M., Ofri R., Ashery-Padan R., Tamm E.R. Reduced expression of Pax6 in lens and cornea of mutant mice leads to failure of chamber angle development and juvenile glaucoma. Hum. Mol. Genet. 2010, 19:3332-3342.
96. Kroeber M., Ohlmann A., Russell P., Tamm E.R. Transgenic studies on the role of optineurin in the mouse eye. Exp. Eye Res. 2006, 82:1075-1085.
97. Kuehn M.H., Kim C.Y., Ostojic J., Bellin M., Alward W.L., Stone E.M., Sakaguchi D.S., Grozdanic S.D., Kwon Y.H. Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp. Eye Res. 2006, 83:620-628.
98. Kuo D.S., Labelle-Dumais C., Gould D.B. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum. Mol. Genet. 2012, 21:R97-R110.
99. Lachke S.A., Alkuraya F.S., Kneeland S.C., Ohn T., Aboukhalil A., Howell G.R., Saadi I., Cavallesco R., Yue Y., Tsai A.C., Nair K.S., Cosma M.I., Smith R.S., Hodges E., Alfadhli S.M., Al-Hajeri A., Shamseldin H.E., Behbehani A., Hannon G.J., Bulyk M.L., Drack A.V., Anderson P.J., John S.W., Maas R.L. Mutations in the RNA granule component TDRD7 cause cataract and glaucoma. Science 2011, 331:1571-1576.
100. Le T.H., Kim H.S., Allen A.M., Spurney R.F., Smithies O., Coffman T.M. Physiological impact of increased expression of the AT1 angiotensin receptor. Hypertension 2003, 42:507-514.
101. Lebrun-Julien F., Di Polo A. Molecular and cell-based approaches for neuroprotection in glaucoma. Optom. Vis. Sci. 2008, 85:417-424.
102. Lee D., Shim M.S., Kim K.Y., Noh Y.H., Kim H., Kim S.Y., Weinreb R.N., Ju W.K. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2014, 55:993-1005.
103. Lei Y., Overby D.R., Boussommier-Calleja A., Stamer W.D., Ethier C.R. Outflow physiology of the mouse eye: pressure dependence and washout. Invest. Ophthalmol. Vis. Sci. 2011, 52:1865-1871.
104. Li G., Farsiu S., Qiu J., Dixon A., Song C., McKinnon S.J., Yuan F., Gonzalez P., Stamer W.D. Disease progression in iridocorneal angle tissues of BMP2-induced ocular hypertensive mice with optical coherence tomography. Mol. Vis. 2014, 20:1695-1709.
105. Li R., Liu J.H. Telemetric monitoring of 24 h intraocular pressure in conscious and freely moving C57BL/6J and CBA/CaJ mice. Mol. Vis. 2008, 14:745-749.
106. Libby R.T., Anderson M.G., Pang I.H., Robinson Z.H., Savinova O.V., Cosma I.M., Snow A., Wilson L.A., Smith R.S., Clark A.F., John S.W. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis. Neurosci. 2005, 22:637-648.
107. Libby R.T., Gould D.B., Anderson M.G., John S.W. Complex genetics of glaucoma susceptibility. Annu. Rev. Genomics Hum. Genet. 2005, 6:15-44.
108. Libby R.T., Li Y., Savinova O.V., Barter J., Smith R.S., Nickells R.W., John S.W. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005, 1:17-26.
109. Libby R.T., Smith R.S., Savinova O.V., Zabaleta A., Martin J.E., Gonzalez F.J., John S.W. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 2003, 299:1578-1581.
110. Lindsey J.D., Weinreb R.N. Identification of the mouse uveoscleral outflow pathway using fluorescent dextran. Invest. Ophthalmol. Vis. Sci. 2002, 43:2201-2205.
111. Lindsey J.D., Weinreb R.N. Elevated intraocular pressure and transgenic applications in the mouse. J. Glaucoma 2005, 14:318-320.
112. Liu J.H., Bouligny R.P., Kripke D.F., Weinreb R.N. Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest. Ophthalmol. Vis. Sci. 2003, 44:4439-4442.
113. Liu P., Fu X., Johnson R.L. Efficient in vivo doxycycline and cre recombinase-mediated inducible transgene activation in the murine trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 2011, 52:969-974.
114. Liu Y., Allingham R.R. Molecular genetics in glaucoma. Exp. Eye Res. 2011, 93:331-339.
115. Lively G.D., Jiang B., Hedberg-Buenz A., Chang B., Petersen G.E., Wang K., Kuehn M.H., Anderson M.G. Genetic dependence of central corneal thickness among inbred strains of mice. Invest. Ophthalmol. Vis. Sci. 2010, 51:160-171.
116. Lively G.D., Koehn D., Hedberg-Buenz A., Wang K., Anderson M.G. Quantitative trait loci associated with murine central corneal thickness. Physiol. Genomics 2010, 42:281-286.
117. Lowe R.F. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma. Br. J. Ophthalmol. 1970, 54:161-169.
118. Lu Y., Vitart V., Burdon K.P., Khor C.C., Bykhovskaya Y., Mirshahi A., Hewitt A.W., Koehn D., Hysi P.G., Ramdas W.D., Zeller T., Vithana E.N., Cornes B.K., Tay W.T., Tai E.S., Cheng C.Y., Liu J., Foo J.N., Saw S.M., Thorleifsson G., Stefansson K., Dimasi D.P., Mills R.A., Mountain J., Ang W., Hoehn R., Verhoeven V.J., Grus F., Wolfs R., Castagne R., Lackner K.J., Springelkamp H., Yang J., Jonasson F., Leung D.Y., Chen L.J., Tham C.C., Rudan I., Vatavuk Z., Hayward C., Gibson J., Cree A.J., MacLeod A., Ennis S., Polasek O., Campbell H., Wilson J.F., Viswanathan A.C., Fleck B., Li X., Siscovick D., Taylor K.D., Rotter J.I., Yazar S., Ulmer M., Li J., Yaspan B.L., Ozel A.B., Richards J.E., Moroi S.E., Haines J.L., Kang J.H., Pasquale L.R., Allingham R.R., Ashley-Koch A., Consortium, N., Mitchell P., Wang J.J., Wright A.F., Pennell C., Spector T.D., Young T.L., Klaver C.C., Martin N.G., Montgomery G.W., Anderson M.G., Aung T., Willoughby C.E., Wiggs J.L., Pang C.P., Thorsteinsdottir U., Lotery A.J., Hammond C.J., van Duijn C.M., Hauser M.A., Rabinowitz Y.S., Pfeiffer N., Mackey D.A., Craig J.E., Macgregor S., Wong T.Y. Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat. Genet. 2013, 45:155-163.
119. Luo N., Conwell M.D., Chen X., Kettenhofen C.I., Westlake C.J., Cantor L.B., Wells C.D., Weinreb R.N., Corson T.W., Spandau D.F., Joos K.M., Iomini C., Obukhov A.G., Sun Y. Primary cilia signaling mediates intraocular pressure sensation. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:12871-12876.
120. Lye-Barthel M., Sun D., Jakobs T.C. Morphology of astrocytes in a glaucomatous optic nerve. Invest. Ophthalmol. Vis. Sci. 2013, 54:909-917.
121. Lyon M.F., Ogunkolade B.W., Brown M.C., Atherton D.J., Perry V.H. A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9717-9720.
122. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., Fernando F.S., Tarlton A., Andressen C., Addicks K., Magni G., Ribchester R.R., Perry V.H., Coleman M.P. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 2001, 4:1199-1206.
123. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
124. Mao M., Hedberg-Buenz A., Koehn D., John S.W., Anderson M.G. Anterior segment dysgenesis and early-onset glaucoma in nee mice with mutation of Sh3pxd2b. Invest. Ophthalmol. Vis. Sci. 2011, 52:2679-2688.
125. Maragakis N.J., Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2006, 2:679-689.
126. Matsubara A., Nakazawa T., Husain D., Iliaki E., Connolly E., Michaud N.A., Gragoudas E.S., Miller J.W. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model. Invest. Ophthalmol. Vis. Sci. 2006, 47:2498-2507.
127. McDowell C.M., Luan T., Zhang Z., Putliwala T., Wordinger R.J., Millar J.C., John S.W., Pang I.H., Clark A.F. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice. Exp. Eye Res. 2012, 100:65-72.
128. McKay B.S., Congrove N.R., Johnson A.A., Dismuke W.M., Bowen T.J., Stamer W.D. A role for myocilin in receptor-mediated endocytosis. PLoS One 2013, 8:e82301.
129. McKeone R., Vieira H., Gregory-Evans K., Gregory-Evans C.Y., Denny P. Foxf2: a novel locus for anterior segment dysgenesis adjacent to the Foxc1 gene. PLoS One 2011, 6:e25489.
130. Menaa F., Braghini C.A., Vasconcellos J.P., Menaa B., Costa V.P., Figueiredo E.S., Melo M.B. Keeping an eye on myocilin: a complex molecule associated with primary open-angle glaucoma susceptibility. Molecules 2011, 16:5402-5421.
131. Minegishi Y., Iejima D., Kobayashi H., Chi Z.L., Kawase K., Yamamoto T., Seki T., Yuasa S., Fukuda K., Iwata T. Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma. Hum. Mol. Genet. 2013, 22:3559-3567.
132. Mo J.S., Anderson M.G., Gregory M., Smith R.S., Savinova O.V., Serreze D.V., Ksander B.R., Streilein J.W., John S.W. By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma. J. Exp. Med. 2003, 197:1335-1344.
133. Monemi S., Spaeth G., DaSilva A., Popinchalk S., Ilitchev E., Liebmann J., Ritch R., Heon E., Crick R.P., Child A., Sarfarazi M. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum. Mol. Genet. 2005, 14:725-733.
134. Moore D., Harris A., Wudunn D., Kheradiya N., Siesky B. Dysfunctional regulation of ocular blood flow: a risk factor for glaucoma?. Clin. Ophthalmol. 2008, 2:849-861.
135. Morgan J.E., Tribble J.R. Microbead models of glaucoma. Exp. Eye Res. 2015, (in this issue).
136. Morquette J.B., Di Polo A. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?. J. Neuroophthalmol. 2008, 28:144-154.
137. Morrison J.C., Cepurna W.O., Johnson E.C. Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure. Exp. Eye Res. 2015, (in this issue).
138. Morrison J.C., Cepurna Ying Guo W.O., Johnson E.C. Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma. Exp. Eye Res. 2011, 93:156-164.
139. Mosaed S., Liu J.H., Weinreb R.N. Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am. J. Ophthalmol. 2005, 139:320-324.
140. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
141. Nagaraju M., Saleh M., Porciatti V. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 2007, 48:4573-4579.
142. Nair K.S., Barbay J., Smith R.S., Masli S., John S.W. Determining immune components necessary for progression of pigment dispersing disease to glaucoma in DBA/2J mice. BMC Genet. 2014, 15:42.
143. Nair K.S., Hmani-Aifa M., Ali Z., Kearney A.L., Ben Salem S., Macalinao D.G., Cosma I.M., Bouassida W., Hakim B., Benzina Z., Soto I., Soderkvist P., Howell G.R., Smith R.S., Ayadi H., John S.W. Alteration of the serine protease PRSS56 causes angle-closure glaucoma in mice and posterior microphthalmia in humans and mice. Nat. Genet. 2011, 43:579-584.
144. Namekata K., Kimura A., Kawamura K., Guo X., Harada C., Tanaka K., Harada T. Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma. Cell. Death Differ. 2013, 20:1250-1256.
145. Napier H.R., Kidson S.H. Molecular events in early development of the ciliary body: a question of folding. Exp. Eye Res. 2007, 84:615-625.
146. Ng S.K., Casson R.J., Burdon K.P., Craig J.E. Chromosome 9p21 primary open-angle glaucoma susceptibility locus: a review. Clin. Exp. Ophthalmol. 2014, 42:25-32.
147. Nguyen J.V., Soto I., Kim K.Y., Bushong E.A., Oglesby E., Valiente-Soriano F.J., Yang Z., Davis C.H., Bedont J.L., Son J.L., Wei J.O., Buchman V.L., Zack D.J., Vidal-Sanz M., Ellisman M.H., Marsh-Armstrong N. Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1176-1181.
148. Nickells R.W. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J. Glaucoma 1996, 5:345-356.
149. Nickells R.W. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv. Ophthalmol. 1999, 43(Suppl. 1):S151-S161.
150. Nickells R.W., Howell G.R., Soto I., John S.W. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu. Rev. Neurosci. 2012, 35:153-179.
151. Nickells R.W., Semaan S.J., Schlamp C.L. Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death. Prog. Brain Res. 2008, 173:423-435.
152. Nusbaum D.M., Wu S.M., Frankfort B.J. Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice. Exp. Eye Res. 2015, 136:38-44.
153. Orr A., Dube M.P., Zenteno J.C., Jiang H., Asselin G., Evans S.C., Caqueret A., Lakosha H., Letourneau L., Marcadier J., Matsuoka M., Macgillivray C., Nightingale M., Papillon-Cavanagh S., Perry S., Provost S., Ludman M., Guernsey D.L., Samuels M.E. Mutations in a novel serine protease PRSS56 in families with nanophthalmos. Mol. Vis. 2011, 17:1850-1861.
154. Orsini F., De Blasio D., Zangari R., Zanier E.R., De Simoni M.G. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front. Cell. Neurosci. 2014, 8:380.
155. Overby D.R., Clark A.F. Animal models of glucocorticoid-induced glaucoma. Exp. Eye Res. 2015, (in this issue).
156. Pang C.P., Leung Y.F., Fan B., Baum L., Tong W.C., Lee W.S., Chua J.K., Fan D.S., Liu Y., Lam D.S. TIGR/MYOC gene sequence alterations in individuals with and without primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2002, 43:3231-3235.
157. Pang I.H., Millar J.C., Clark A.F. Elevation of intraocular pressure in rodents using viral vectors targeting the trabecular meshwork. Exp. Eye Res. 2015, (in this issue).
158. Park D.Y., Lee J., Park I., Choi D., Lee S., Song S., Hwang Y., Hong K.Y., Nakaoka Y., Makinen T., Kim P., Alitalo K., Hong Y.K., Koh G.Y. Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity. J. Clin. Invest. 2014, 124:3960-3974.
159. Perry V.H., Brown M.C., Tsao J.W. The effectiveness of the gene which slows the rate of Wallerian degeneration in C57BL/Ola mice declines with age. Eur. J. Neurosci. 1992, 4:1000-1002.
160. Polansky J.R., Fauss D.J., Chen P., Chen H., Lutjen-Drecoll E., Johnson D., Kurtz R.M., Ma Z.D., Bloom E., Nguyen T.D. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 1997, 211:126-139.
161. Prasanna G., Hulet C., Desai D., Krishnamoorthy R.R., Narayan S., Brun A.M., Suburo A.M., Yorio T. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol. Res. 2005, 51:41-50.
162. Prasanna G., Krishnamoorthy R., Clark A.F., Wordinger R.J., Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest. Ophthalmol. Vis. Sci. 2002, 43:2704-2713.
163. Prasanna G., Krishnamoorthy R., Yorio T. Endothelin, astrocytes and glaucoma. Exp. Eye Res. 2011, 93:170-177.
164. Prasov L., Nagy M., Rudolph D.D., Glaser T. Math5 (Atoh7) gene dosage limits retinal ganglion cell genesis. Neuroreport 2012, 23:631-634.
165. Quigley H., Anderson D.R. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest. Ophthalmol. 1976, 15:606-616.
166. Quigley H.A. Angle-closure glaucoma-simpler answers to complex mechanisms: LXVI Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 2009, 148:657-669. e651.
167. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 1980, 19:137-152.
168. Quigley H.A., Addicks E.M. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch. Ophthalmol. 1981, 99:137-143.
169. Quigley H.A., Nickells R.W., Kerrigan L.A., Pease M.E., Thibault D.J., Zack D.J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 1995, 36:774-786.
170. Rattner A., Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J. Neurosci. 2005, 25:4540-4549.
171. Reis L.M., Semina E.V. Genetics of anterior segment dysgenesis disorders. Curr. Opin. Ophthalmol. 2011, 22:314-324.
172. Ren L., Danias J. A role for complement in glaucoma?. Adv. Exp. Med. Biol. 2010, 703:95-104.
173. Resch Z.T., Fautsch M.P. Glaucoma-associated myocilin: a better understanding but much more to learn. Exp. Eye Res. 2009, 88:704-712.
174. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., Heon E., Krupin T., Ritch R., Kreutzer D., Crick R.P., Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295:1077-1079.
175. Ritch R., Darbro B., Menon G., Khanna C.L., Solivan-Timpe F., Roos B.R., Sarfarzi M., Kawase K., Yamamoto T., Robin A.L., Lotery A.J., Fingert J.H. TBK1 gene duplication and normal-tension glaucoma. JAMA Ophthalmol. 2014, 132:544-548.
176. Sander J.D., Joung J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 2014, 32:347-355.
177. Sarode B., Nowell C.S., Ihm J., Kostic C., Arsenijevic Y., Moulin A.P., Schorderet D.F., Beermann F., Radtke F. Notch signaling in the pigmented epithelium of the anterior eye segment promotes ciliary body development at the expense of iris formation. Pigment Cell Melanoma Res. 2014, 27:580-589.
178. Savinova O.V., Sugiyama F., Martin J.E., Tomarev S.I., Paigen B.J., Smith R.S., John S.W. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001, 2:12.
179. Schlamp C.L., Li Y., Dietz J.A., Janssen K.T., Nickells R.W. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006, 7:66.
180. Schmucker C., Schaeffel F. A paraxial schematic eye model for the growing C57BL/6 mouse. Vis. Res. 2004, 44:1857-1867.
181. Schofield P.N., Hoehndorf R., Gkoutos G.V. Mouse genetic and phenotypic resources for human genetics. Hum. Mutat. 2012, 33:826-836.
182. Schuettauf F., Quinto K., Naskar R., Zurakowski D. Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vis. Res. 2002, 42:2333-2337.
183. Seitz R., Ohlmann A., Tamm E.R. The role of Muller glia and microglia in glaucoma. Cell. Tissue Res. 2013, 353:339-345.
184. Semba K., Namekata K., Guo X., Harada C., Harada T., Mitamura Y. Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma. Cell. Death Dis. 2014, 5:e1333.
185. Senatorov V., Malyukova I., Fariss R., Wawrousek E.F., Swaminathan S., Sharan S.K., Tomarev S. Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J. Neurosci. 2006, 26:11903-11914.
186. Shepard A.R., Jacobson N., Millar J.C., Pang I.H., Steely H.T., Searby C.C., Sheffield V.C., Stone E.M., Clark A.F. Glaucoma-causing myocilin mutants require the peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum. Mol. Genet. 2007, 16:609-617.
187. Shoshani Y.Z., Harris A., Shoja M.M., Rusia D., Siesky B., Arieli Y., Wirostko B. Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma. Curr. Eye Res. 2012, 37:1-11.
188. Siddiqui Y., Ten Hulzen R.D., Cameron J.D., Hodge D.O., Johnson D.H. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome?. Am. J. Ophthalmol. 2003, 135:794-799.
189. Smith R.S., Korb D., John S.W. A goniolens for clinical monitoring of the mouse iridocorneal angle and optic nerve. Mol. Vis. 2002, 8:26-31.
190. Smith R.S., Zabaleta A., Kume T., Savinova O.V., Kidson S.H., Martin J.E., Nishimura D.Y., Alward W.L., Hogan B.L., John S.W. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum. Mol. Genet. 2000, 9:1021-1032.
191. Smith R.S., Zabaleta A., Savinova O.V., John S.W. The mouse anterior chamber angle and trabecular meshwork develop without cell death. BMC Dev. Biol. 2001, 1:3.
192. Smithies O., Kim H.S. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3612-3615.
193. Soto I., Howell G.R. The complex role of neuroinflammation in glaucoma. Cold Spring Harb. Perspect. Med. 2014, 4.
194. Sowden J.C. Molecular and developmental mechanisms of anterior segment dysgenesis. Eye Lond. 2007, 21:1310-1318.
195. Springelkamp H., Hohn R., Mishra A., Hysi P.G., Khor C.C., Loomis S.J., Bailey J.N., Gibson J., Thorleifsson G., Janssen S.F., Luo X., Ramdas W.D., Vithana E., Nongpiur M.E., Montgomery G.W., Xu L., Mountain J.E., Gharahkhani P., Lu Y., Amin N., Karssen L.C., Sim K.S., van Leeuwen E.M., Iglesias A.I., Verhoeven V.J., Hauser M.A., Loon S.C., Despriet D.D., Nag A., Venturini C., Sanfilippo P.G., Schillert A., Kang J.H., Landers J., Jonasson F., Cree A.J., van Koolwijk L.M., Rivadeneira F., Souzeau E., Jonsson V., Menon G., Blue Mountains Eye Study, G.g., Weinreb R.N., de Jong P.T., Oostra B.A., Uitterlinden A.G., Hofman A., Ennis S., Thorsteinsdottir U., Burdon K.P., Consortium, N., Wellcome Trust Case Control, C., Spector T.D., Mirshahi A., Saw S.M., Vingerling J.R., Teo Y.Y., Haines J.L., Wolfs R.C., Lemij H.G., Tai E.S., Jansonius N.M., Jonas J.B., Cheng C.Y., Aung T., Viswanathan A.C., Klaver C.C., Craig J.E., Macgregor S., Mackey D.A., Lotery A.J., Stefansson K., Bergen A.A., Young T.L., Wiggs J.L., Pfeiffer N., Wong T.Y., Pasquale L.R., Hewitt A.W., van Duijn C.M., Hammond C.J. Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process. Nat. Commun. 2014, 5:4883.
196. Stasi K., Nagel D., Yang X., Wang R.F., Ren L., Podos S.M., Mittag T., Danias J. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2006, 47:1024-1029.
197. Steinhart M.R., Cone F.E., Nguyen C., Nguyen T.D., Pease M.E., Puk O., Graw J., Oglesby E.N., Quigley H.A. Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model. Mol. Vis. 2012, 18:1093-1106.
198. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
199. Stone E.M., Fingert J.H., Alward W.L., Nguyen T.D., Polansky J.R., Sunden S.L., Nishimura D., Clark A.F., Nystuen A., Nichols B.E., Mackey D.A., Ritch R., Kalenak J.W., Craven E.R., Sheffield V.C. Identification of a gene that causes primary open angle glaucoma. Science 1997, 275:668-670.
200. Takahashi N., Smithies O. Human genetics, animal models and computer simulations for studying hypertension. Trends Genet. 2004, 20:136-145.
201. Tamm E.R., Russell P., Epstein D.L., Johnson D.H., Piatigorsky J. Modulation of myocilin/TIGR expression in human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 1999, 40:2577-2582.
202. Tezel G., Yang X., Luo C., Kain A.D., Powell D.W., Kuehn M.H., Kaplan H.J. Oxidative stress and the regulation of complement activation in human glaucoma. Invest. Ophthalmol. Vis. Sci. 2010, 51:5071-5082.
203. Thomson B.R., Heinen S., Jeansson M., Ghosh A.K., Fatima A., Sung H.K., Onay T., Chen H., Yamaguchi S., Economides A.N., Flenniken A., Gale N.W., Hong Y.K., Fawzi A., Liu X., Kume T., Quaggin S.E. A lymphatic defect causes ocular hypertension and glaucoma in mice. J. Clin. Invest. 2014, 124:4320-4324.
204. Trantow C.M., Mao M., Petersen G.E., Alward E.M., Alward W.L., Fingert J.H., Anderson M.G. Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome. Invest. Ophthalmol. Vis. Sci. 2009, 50:1205-1214.
205. Tseng H.C., Riday T.T., McKee C., Braine C.E., Bomze H., Barak I., Marean-Reardon C., John S.W., Philpot B.D., Ehlers M.D. Visual impairment in an optineurin mouse model of primary open-angle glaucoma. Neurobiol. Aging 2015, 36:2201-2212.
206. Tucker B.A., Solivan-Timpe F., Roos B.R., Anfinson K.R., Robin A.L., Wiley L.A., Mullins R.F., Fingert J.H. Duplication of TBK1 stimulates autophagy in iPSC-derived retinal cells from a patient with normal tension glaucoma. J. Stem Cell. Res. Ther. 2014, 3:161.
207. Urnov F.D., Rebar E.J., Holmes M.C., Zhang H.S., Gregory P.D. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 2010, 11:636-646.
208. Van Agtmael T., Schlotzer-Schrehardt U., McKie L., Brownstein D.G., Lee A.W., Cross S.H., Sado Y., Mullins J.J., Poschl E., Jackson I.J. Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum. Mol. Genet. 2005, 14:3161-3168.
209. van der Weyden L., Bradley A. Mouse chromosome engineering for modeling human disease. Annu. Rev. Genomics Hum. Genet. 2006, 7:247-276.
210. van der Weyden L., White J.K., Adams D.J., Logan D.W. The mouse genetics toolkit: revealing function and mechanism. Genome Biol. 2011, 12:224.
211. Verkhratsky A., Parpura V., Pekna M., Pekny M., Sofroniew M. Glia in the pathogenesis of neurodegenerative diseases. Biochem. Soc. Trans. 2014, 42:1291-1301.
212. Verouti S.N., Boscardin E., Hummler E., Frateschi S. Regulation of blood pressure and renal function by NCC and ENaC: lessons from genetically engineered mice. Curr. Opin. Pharmacol. 2015, 21:60-72.
213. Wang W.H., Millar J.C., Pang I.H., Wax M.B., Clark A.F. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest. Ophthalmol. Vis. Sci. 2005, 46:4617-4621.
214. Ward N.J., Ho K.W., Lambert W.S., Weitlauf C., Calkins D.J. Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection. J. Neurosci. 2014, 34:3161-3170.
215. Weidberg H., Elazar Z. TBK1 mediates crosstalk between the innate immune response and autophagy. Sci. Signal 2011, 4:e39.
216. Weng J., Luo J., Cheng X., Jin C., Zhou X., Qu J., Tu L., Ai D., Li D., Wang J., Martin J.F., Amendt B.A., Liu M. Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6081-6086.
217. Whitlock N.A., McKnight B., Corcoran K.N., Rodriguez L.A., Rice D.S. Increased intraocular pressure in mice treated with dexamethasone. Invest. Ophthalmol. Vis. Sci. 2010, 51:6496-6503.
218. Whitmore A.V., Libby R.T., John S.W. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes?. Prog. Retin. Eye Res. 2005, 24:639-662.
219. Wiggs J.L., Hauser M.A., Abdrabou W., Allingham R.R., Budenz D.L., Delbono E., Friedman D.S., Kang J.H., Gaasterland D., Gaasterland T., Lee R.K., Lichter P.R., Loomis S., Liu Y., McCarty C., Medeiros F.A., Moroi S.E., Olson L.M., Realini A., Richards J.E., Rozsa F.W., Schuman J.S., Singh K., Stein J.D., Vollrath D., Weinreb R.N., Wollstein G., Yaspan B.L., Yoneyama S., Zack D., Zhang K., Pericak-Vance M., Pasquale L.R., Haines J.L. The NEIGHBOR consortium primary open-angle glaucoma genome-wide association study: rationale, study design, and clinical variables. J. Glaucoma 2013, 22:517-525.
220. Wiggs J.L., Yaspan B.L., Hauser M.A., Kang J.H., Allingham R.R., Olson L.M., Abdrabou W., Fan B.J., Wang D.Y., Brodeur W., Budenz D.L., Caprioli J., Crenshaw A., Crooks K., Delbono E., Doheny K.F., Friedman D.S., Gaasterland D., Gaasterland T., Laurie C., Lee R.K., Lichter P.R., Loomis S., Liu Y., Medeiros F.A., McCarty C., Mirel D., Moroi S.E., Musch D.C., Realini A., Rozsa F.W., Schuman J.S., Scott K., Singh K., Stein J.D., Trager E.H., Vanveldhuisen P., Vollrath D., Wollstein G., Yoneyama S., Zhang K., Weinreb R.N., Ernst J., Kellis M., Masuda T., Zack D., Richards J.E., Pericak-Vance M., Pasquale L.R., Haines J.L. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet. 2012, 8:e1002654.
221. Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., Richter B., Korac J., Waidmann O., Choudhary C., Dotsch V., Bumann D., Dikic I. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011, 333:228-233.
222. Williams P.A., Howell G.R., Barbay J.M., Braine C.E., Sousa G.L., John S.W., Morgan J.E. Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma. PLoS One 2013, 8:e72282.
223. Wong A.A., Brown R.E. A neurobehavioral analysis of the prevention of visual impairment in the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2012, 53:5956-5966.
224. Wong A.A., Brown R.E. Prevention of vision loss protects against age-related impairment in learning and memory performance in DBA/2J mice. Front. Aging Neurosci. 2013, 5:52.
225. Yan X., Sabrautzki S., Horsch M., Fuchs H., Gailus-Durner V., Beckers J., Hrabe de Angelis M., Graw J. Peroxidasin is essential for eye development in the mouse. Hum. Mol. Genet. 2014, 23:5597-5614.
226. Ylikarppa R., Eklund L., Sormunen R., Kontiola A.I., Utriainen A., Maatta M., Fukai N., Olsen B.R., Pihlajaniemi T. Lack of type XVIII collagen results in anterior ocular defects. FASEB J. 2003, 17:2257-2259.
227. Yu D.Y., Cringle S.J., Balaratnasingam C., Morgan W.H., Yu P.K., Su E.N. Retinal ganglion cells: energetics, compartmentation, axonal transport, cytoskeletons and vulnerability. Prog. Retin. Eye Res. 2013, 36:217-246.
228. Zhang Y., Davidson B.R., Stamer W.D., Barton J.K., Marmorstein L.Y., Marmorstein A.D. Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice. Invest. Ophthalmol. Vis. Sci. 2009, 50:765-770.
229. Zhou X., Li F., Kong L., Tomita H., Li C., Cao W. Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J. Biol. Chem. 2005, 280:31240-31248.
230. Zhou Y., Grinchuk O., Tomarev S.I. Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest. Ophthalmol. Vis. Sci. 2008, 49:1932-1939.
231. Zhou Y., Tanzie C., Yan Z., Chen S., Duncan M., Gaudenz K., Li H., Seidel C., Lewis B., Moran A., Libby R.T., Kiernan A.E., Xie T. Notch2 regulates BMP signaling and epithelial morphogenesis in the ciliary body of the mouse eye. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8966-8971.
232. Zillig M., Wurm A., Grehn F.J., Russell P., Tamm E.R. Overexpression and properties of wild-type and Tyr437His mutated myocilin in the eyes of transgenic mice. Invest. Ophthalmol. Vis. Sci. 2005, 46:223-234.
233. Zode G.S., Kuehn M.H., Nishimura D.Y., Searby C.C., Mohan K., Grozdanic S.D., Bugge K., Anderson M.G., Clark A.F., Stone E.M., Sheffield V.C. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J. Clin. Invest. 2011, 121:3542-3553.